Document Detail

Cardiac Encephalopathy.
MedLine Citation:
PMID:  15096313     Owner:  NLM     Status:  Publisher    
Many patients develop confusion, lethargy, and cognitive and behavioral abnormalities during or after cardiac decompensation. Congestive heart failure and the accompanying elevation in systemic venous pressure and decrease in cardiac output can lead to changes within the cranial cavity that cause an encephalopathy. At times, excess cerebrospinal fluid accumulates within the cranium causing an apathetic state identical to that seen in patients with other causes of hydrocephalus. Awareness of the syndrome of cardiac encephalopathy and optimal management of congestive heart failure and body fluids can reverse the neurologic dysfunction. In some patients with excess cerebrospinal fluid, lumbar puncture with removal of cerebrospinal fluid can reverse the apathetic state.
Louis R. Caplan
Related Documents :
7148503 - Effects of red rest and prazosin in congestive heart failure.
24262613 - Systematic use of transradial pci in patients with st-segment elevation myocardial infa...
17906353 - High-risk left main coronary stenting supported by percutaneous impella recover lp 2.5 ...
Publication Detail:
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  6     ISSN:  1534-3189     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-Apr-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  217-222     Citation Subset:  -    
Beth Israel Deaconess Medical Center.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hypertensive Encephalopathy.
Next Document:  Stroke in Patients with Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.